CivicaScripts Contracts With Catalent To Make Low-Cost Generics

By John Wilkerson / June 17, 2021 at 10:25 AM
CivicaScripts will contract with drug manufacturer Catalent to make low-priced versions of expensive generic drugs, and the company is partnering with Anthem, which operates affiliated health plans that provide health coverage to more than 43 million Americans, Civica Rx announced Wednesday (June 16). CivicaScripts will submit generic drug applications for six to 10 drugs that it is not yet disclosing due to competitive concerns. Anthem joins CivicaScripts’ co-founders, Blue Cross Blue Shield Association and 17 independent and locally-operated Blue Cross...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.